Advanced Health Limited has completed a partially underwritten non-renounceable rights offer
Advanced Health Limited has raised funds.
Advanced Health owns and operates a network of day hospitals across South Africa. Listed on the Johannesburg Stock Exchange in 2014, it has established itself as a leader in day surgery across the country. Through its subsidiary Presmed Australia, Advanced Health invests in various day hospitals in Australia.
Oaklins’ team in South Africa acted as corporate and designated advisor in this transaction.
Talk to the deal team
Annerie Britz
Oaklins South Africa
Related deals
Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.
Learn moreOmer Engineering has completed an IPO
Omer Engineering Ltd. has successfully launched its IPO on the Tel Aviv Stock Exchange, pricing shares as part of a plan to raise approximately US$94 million at an implied pre-money valuation of around US$313 million. The offering included both newly issued shares and a secondary sale by existing shareholders, who retained a significant majority stake post-IPO. This transaction underscores strong investor interest in scaling the company’s operations and enhancing its capital.
Learn moreSmart Capital has finalized a rights issue
Smart Capital S.p.A. has finalized a rights issue to continue executing its growth plan and increase its investment capacity. The fundraising supports the expansion of its investment portfolio and the strengthening of its positions in higher-quality investee companies with stronger growth prospects.
Learn more